Identification of Genes Associated with Papillary Thyroid Carcinoma (PTC) for Diagnosis by Integrated Analysis

被引:12
作者
Li, W. -B. [1 ]
Zhou, J. [1 ]
Xu, L. [1 ]
Su, X. -L. [2 ]
Liu, Q. [1 ]
Pang, H. [1 ]
机构
[1] Med Univ, Affiliated Hosp Chongqing 1, Dept Nucl Med, Chongqing, Peoples R China
[2] Med Univ, Affiliated Hosp Chongqing 1, Dept Endocrine Breast Surg, Chongqing, Peoples R China
关键词
papillary thyroid carcinoma; integrated analysis; differentially expressed genes; WILMS-TUMOR; EXPRESSION; CANCER; ACTIVATION; PROGRESSION; MECHANISMS; NEOPLASMS; FIBULINS; RECEPTOR; CADHERIN;
D O I
10.1055/s-0035-1569289
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Papillary thyroid carcinoma (PTC) is the most common type of thyroid carcinoma, and our understanding of its pathogenesis is incomplete. To elucidate the mechanisms underlying such progression and identify novel diagnostic markers, we aimed to discover the underlying gene associated with PTC. Integrated analysis of microarray datasets was performed to identify differentially expressed genes (DEGs) between PTCs and normal tissues. GO enrichment analysis and KEGG pathway enrichment analysis were then performed to uncover the functions of DEGs. Furthermore, the protein-protein interaction (PPI) network of DEGs was constructed. Five GEO datasets were obtained. Totally, 154 DEGs across the studies were identified, including 26 upregulated and 128 downregulated DEGs. In the PPI network, MLLT1, DLG2, and EFEMP1 were the hub proteins, in which DLG2 and EFEMP1 were involved in tumor progression. Among the top 10 up- and downregulated genes, the dysregulation genes of TPO, CDH16, and MPPED2 may be closely related to the tumorigenesis of PTC. By integrated analysis of multiple gene expression profiles, we propose that the dysregulation genes of TPO and MPPED2 will be the promising diagnostic markers for PTCs.
引用
收藏
页码:226 / 231
页数:6
相关论文
共 46 条
[1]  
[Anonymous], 2018, ANTI-CANCER DRUG, DOI [DOI 10.3322/caac.20115, DOI 10.1097/CAD.0000000000000617]
[2]   Fibulins: physiological and disease perspectives [J].
Argraves, WS ;
Greene, LM ;
Cooley, MA ;
Gallagher, WM .
EMBO REPORTS, 2003, 4 (12) :1127-1131
[3]   Gene Ontology: tool for the unification of biology [J].
Ashburner, M ;
Ball, CA ;
Blake, JA ;
Botstein, D ;
Butler, H ;
Cherry, JM ;
Davis, AP ;
Dolinski, K ;
Dwight, SS ;
Eppig, JT ;
Harris, MA ;
Hill, DP ;
Issel-Tarver, L ;
Kasarskis, A ;
Lewis, S ;
Matese, JC ;
Richardson, JE ;
Ringwald, M ;
Rubin, GM ;
Sherlock, G .
NATURE GENETICS, 2000, 25 (01) :25-29
[4]   Involvement of Members of the Cadherin Superfamily in Cancer [J].
Berx, Geert ;
van Roy, Frans .
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2009, 1 (06) :a003129
[5]   WILMS-TUMOR LOCUS ON 11P13 DEFINED BY MULTIPLE CPG ISLAND-ASSOCIATED TRANSCRIPTS [J].
BONETTA, L ;
KUEHN, SE ;
HUANG, A ;
LAW, DJ ;
KALIKIN, LM ;
KOI, M ;
REEVE, AE ;
BROWNSTEIN, BH ;
YEGER, H ;
WILLIAMS, BRG ;
FEINBERG, AP .
SCIENCE, 1990, 250 (4983) :994-997
[6]  
BONGARZONE I, 1989, ONCOGENE, V4, P1457
[7]   CDH16/Ksp-Cadherin Is Expressed in the Developing Thyroid Gland and Is Strongly Down-Regulated in Thyroid Carcinomas [J].
Call, Gaetano ;
Gentile, Flaviana ;
Mogavero, Sara ;
Pallante, Pierlorenzo ;
Nitsch, Roberto ;
Ciancia, Giuseppe ;
Ferraro, Angelo ;
Fusco, Alfredo ;
Nitsch, Lucio .
ENDOCRINOLOGY, 2012, 153 (01) :522-534
[8]   EFEMP1 binds the EGF receptor and activates MAPK and Akt pathways in pancreatic carcinoma cells [J].
Camaj, Peter ;
Seeliger, Hendrik ;
Ischenko, Ivan ;
Krebs, Stefan ;
Blum, Helmut ;
De Toni, Enrico N. ;
Faktorova, Dagmar ;
Jauch, Karl-Walter ;
Bruns, Christiane J. .
BIOLOGICAL CHEMISTRY, 2009, 390 (12) :1293-1302
[9]   Ras oncogene mutations in thyroid tumors - Polymerase chain reaction-restriction-fragment-length polymorphism analysis from paraffin-embedded tissues [J].
Capella, G ;
MatiasGuiu, X ;
Ampudia, X ;
deLeiva, A ;
Perucho, M ;
Prat, J .
DIAGNOSTIC MOLECULAR PATHOLOGY, 1996, 5 (01) :45-52
[10]   Increasing Incidence of Differentiated Thyroid Cancer in the United States, 1988-2005 [J].
Chen, Amy Y. ;
Jemal, Ahmedin ;
Ward, Elizabeth M. .
CANCER, 2009, 115 (16) :3801-3807